ACAD — ACADIA PHARMACEUTICALS INC

Ownership history in Deep Track Capital, LP  ·  3 quarters on record

This page tracks every 13F SEC filing in which Deep Track Capital, LP reported a position in ACADIA PHARMACEUTICALS INC (ACAD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.65% (2021 Q4)
Avg. % of fund
1.11%
First filed
2021 Q4
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 105,085 -1,628,045 -93.9% 0.06% $2.2M $21.34
2022 Q2 ADDED 1,733,130 +733,130 +73.3% 1.61% $24.4M $14.09
2021 Q4 INITIATED 1,000,000 — — 1.65% $23.3M $23.34
% of Fund (quarterly)    ACAD price (monthly, adj. close)

Other funds also holding ACAD

As of 2025 Q4 — sorted by position size

Palo Alto Investors LP 3Y 7Y 9.24% BAKER BROS. ADVISORS LP 3Y 7Y 6.71% Birchview Capital, LP 3Y 7Y 2.67% Nan Fung Group Holdings Ltd 3Y 2.46% Axecap Investments, LLC 2.25% Stonepine Capital Management, LLC 3Y 7Y 1.95% RTW INVESTMENTS, LP 3Y 7Y 1.91% BRAIDWELL LP 3Y 1.74% Logos Global Management LP 3Y 1.37% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 1.1%
← Back to Deep Track Capital, LP Holdings